Overview

• Hims & Hers has acquired New Jersey-based Trybe Labs, enabling at-home blood draws and lab testing for its users.
• The new service will provide tests for hormone levels, cardiac risk, cholesterol, liver function, thyroid function, and more, with results used to create personalized treatment plans.
• The acquisition was funded through cash on hand, though the company has not disclosed the transaction's financial details.
• Hims & Hers plans to use de-identified data from the tests to advance its AI initiatives, including its MedMatch tool for recommending personalized treatments.
• The company’s stock surged over 18% following the announcement, despite facing significant short interest and a recent Morgan Stanley downgrade.